← Leaderboards
Gerhard A Coetzee
University Of Southern California
$12,049,244
Attributed
$13,806,780
Total exposure
7
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2006–24$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$13,806,780 · 7
By mechanism
R01$12,568,856 · 5
P30$1,237,924 · 2
Top collaborators
- Peggy J Farnham5 shared
- Wange Lu4 shared
Most similar at University Of Southern California
Same institution · by research overlap
- Caryn Lerman$95,133,528
- Heinz Josef Lenz$20,123,312
- David Ian Quinn$4,779,068
- Anthony Boutros El-Khoueiry$6,814,457
- Michael R Lieber$20,714,841
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesGene ExpressionGenomicsMalignant NeoplasmsAffectLinkPhenotypeInsightTranscription FactorSingle Nucleotide PolymorphismRisk VariantCancer RiskGene TargetingChromatinGeneticGenome-WideDna MethylationGenetic StudyLeadAndrogen ReceptorCellsPredispositionEnhancersAlleles
Grant awards (38)
Epigenetic contributions to symptom asymmetry in Parkinson's disease$433,105
R01 · FY2024 · NS · contact PI
Epigenetic contributions to symptom asymmetry in Parkinson's disease$446,500
R01 · FY2023 · NS · contact PI
Epigenetic contributions to symptom asymmetry in Parkinson's disease$446,500
R01 · FY2022 · NS · contact PI
Epigenetic contributions to symptom asymmetry in Parkinson's disease$446,500
R01 · FY2021 · NS · contact PI
Epigenetic contributions to symptom asymmetry in Parkinson's disease$446,500
R01 · FY2020 · NS · contact PI
Prostate Cancer Risk Enhancers$524,114
R01 · FY2019 · CA
Breast Cancer Risk Enhancers$421,585
R01 · FY2019 · CA · contact PI
Prostate Cancer Risk Enhancers$548,636
R01 · FY2018 · CA
Breast Cancer Risk Enhancers$434,625
R01 · FY2018 · CA · contact PI
Prostate Cancer Risk Enhancers$556,779
R01 · FY2017 · CA
Breast Cancer Risk Enhancers$434,625
R01 · FY2017 · CA · contact PI
Prostate Cancer Risk Enhancers$564,927
R01 · FY2016 · CA
Breast Cancer Risk Enhancers$434,625
R01 · FY2016 · CA · contact PI
Prostate Cancer Risk Enhancers$572,877
R01 · FY2015 · CA · contact PI
Breast Cancer Risk Enhancers$376,961
R01 · FY2015 · CA · contact PI
Genomic Enhancers at 8q24 and Prostate Cancer$399,702
R01 · FY2014 · CA · contact PI
Genomic Enhancers at 8q24 and Prostate Cancer$398,010
R01 · FY2013 · CA · contact PI
Genomic Enhancers at 8q24 and Prostate Cancer$612,476
R01 · FY2012 · CA · contact PI
Genomic Enhancers at 8q24 and Prostate Cancer$612,060
R01 · FY2011 · CA · contact PI
Genomic Enhancers at 8q24 and Prostate Cancer$659,462
R01 · FY2010 · CA · contact PI
Genetics Core Laboratory$287,920
P30 · FY2010 · CA · contact PI
AR and RUNX2 target genes in prostate cancer$252,841
R01 · FY2010 · CA · contact PI
Genetics Core Laboratory$292,012
P30 · FY2009 · CA · contact PI
AR and RUNX2 target genes in prostate cancer$252,841
R01 · FY2009 · CA · contact PI
AR and RUNX2 target genes in prostate cancer$252,841
R01 · FY2008 · CA · contact PI
Genetics Core Laboratory$250,028
P30 · FY2008 · CA · contact PI
Genetics Core Laboratory$281,147
P30 · FY2007 · CA · contact PI
AR and RUNX2 target genes in prostate cancer$252,841
R01 · FY2007 · CA · contact PI
AR and RUNX2 target genes in prostate cancer$317,110
R01 · FY2006 · CA · contact PI
Genetics Core Laboratory$126,817
P30 · FY2006 · CA · contact PI
ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE$369,015
R01 · FY2003 · CA
ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE$361,780
R01 · FY2002 · CA
CORE--GENOMICS$0
P30 · FY2002 · CA
CORE--GENOMICS$0
P30 · FY2002 · CA
ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE$355,025
R01 · FY2001 · CA
CORE--GENOMICS$0
P30 · FY2001 · CA
CORE--GENOMICS$0
P30 · FY2001 · CA
ANDROGEN RECEPTOR AND PROSTATE CANCER RISK IN CHINESE$383,993
R01 · FY2000 · CA